Skip to main content

Immune RadioBiology

Section edited by Claire Vanpouille-Box

The Iummne RadioBiology section is interested in innovative research that investigate the crosstalk between ionizing radiations (IR), the tumor microenvironment (TME) and host immunity. 

Studies considered for publication include (but not limited to) those investigating the mechanisms of radiation-induced anti-tumor immune responses, the immune-stimulatory and immuno-suppressive properties of ionizing radiation from all sources (X-rays, FLASH-RT, protons, carbon ion and radionuclides), biomarkers predictive of immune response, immune escape mechanisms elicited by IR and radioresistance. Importantly, the section welcomes translational and clinical studies assessing the combination of IR with immunotherapies (IT) with an emphasis on clinical response and outcome.

Page 2 of 2

  1. Radiotherapy is among the routine treatment options for malignant tumors. And it damages DNA and other cellular organelles in target cells by using ionizing radiation produced by various rays, killing the cell...

    Authors: Huihui Sun, Rui Sun, Xing Song, Wendong Gu and Yingjie Shao
    Citation: Journal of Translational Medicine 2022 20:189
    Content type: Review Published on:

  2. Medical applications of ionising radiation and associated radiation protection research often encounter long delays and inconsistent implementation when translated into clinical practice. A coordinated effort ...

    Authors: Sophie Bockhold, Shane J. Foley, Louise A. Rainford, Riccardo Corridori, Annika Eberstein, Christoph Hoeschen, Mark W. Konijnenberg, Susan Molyneux-Hodgson, Graciano Paulo, Joana Santos and Jonathan P. McNulty
    Citation: Journal of Translational Medicine 2022 20:137
    Content type: Research Published on:

  3. Histone deacetylases (HDACs) have been identified to be implicated in the carcinogenesis and cancer progression. The present study was performed to probe into the effect of HDAC4 on radioresistance of esophage...

    Authors: Zhonghua Lu, Yifei Yun, Yutong Zhang, Yao Ou and Meihua Wang
    Citation: Journal of Translational Medicine 2022 20:101
    Content type: Research Published on:

  4. Epidermal growth factor receptor (EGFR)-mutant lung cancers have a high risk of developing brain metastases (BM). Whole brain radiotherapy (WBRT), local radiotherapy, and WBRT + Boost are frequently used for trea...

    Authors: Guangchuan Deng, Yingyun Zhang, Jiaojiao Ke, Qi Wang, Hongyue Qin, Jianbin Li and Zhenxiang Li
    Citation: Journal of Translational Medicine 2021 19:486
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Translational Medicine 2021 19:503

  5. Most head and neck cancer (HNC) patients receive radiotherapy (RT) and develop toxicities. This genome-wide association study (GWAS) was designed to identify single nucleotide polymorphisms (SNPs) associated w...

    Authors: Elnaz Naderi, Anne Petra Gerarda Crijns, Roel Johannes Henricus Marinus Steenbakkers, Johanna Geertruida Maria van den Hoek, Hendrika Marike Boezen, Behrooz Ziad Alizadeh and Johannes Albertus Langendijk
    Citation: Journal of Translational Medicine 2021 19:481
    Content type: Research Published on:

  6. Radiotherapy (RT) still represents a mainstay of treatment in clinical oncology. Traditionally, the effectiveness of radiotherapy has been attributed to the killing potential of ionizing radiation (IR) over ma...

    Authors: Turid Hellevik, Rodrigo Berzaghi, Kristin Lode, Ashraful Islam and Inigo Martinez-Zubiaurre
    Citation: Journal of Translational Medicine 2021 19:437
    Content type: Review Published on:

  7. Compared to the other members of human epidermal growth factor family receptors (HER), the role of HER3 has not been well defined in laryngeal cancer. The predictive and prognostic role of HER3 has been the fo...

    Authors: Giovanni Almadori, Antonella Coli, Eugenio De Corso, Dario Antonio Mele, Stefano Settimi, Giovanni Di Cintio, Francesca Brigato, Domenico Scannone, Thomas E. Carey, Gaetano Paludetti, Libero Lauriola and Franco Oreste Ranelletti
    Citation: Journal of Translational Medicine 2021 19:408
    Content type: Research Published on:

  8. Solute carrier family 7 member 11(SLC7A11) is a component of cysteine/glutamate transporter, which plays a key role in tumor growth; however, its underlying effect on radiosensitivity in esophageal squamous ce...

    Authors: Lei Feng, Kaikai Zhao, Liangchao Sun, Xiaoyang Yin, Junpeng Zhang, Conghe Liu and Baosheng Li
    Citation: Journal of Translational Medicine 2021 19:367
    Content type: Research Published on:

  9. Although reports implicate radioresistance as an important obstacle for the management of breast cancer, its molecular mechanism is elusive. Herein, we found that high HDGF levels are expressed significantly i...

    Authors: Lingyun Qiu, Yan Ma, Xiaohua Chen, Liheng Zhou, Haibo Zhang, Guansheng Zhong, Lei Zhang and Jianming Tang
    Citation: Journal of Translational Medicine 2021 19:344
    Content type: Research Published on:

  10. Radiotherapy is the mainstay treatment for lung adenocarcinoma, yet remains highly susceptible to resistance. Fe3O4 magnetic nanoparticles (MNPs) possess the ability to induce biological therapeutic effects. Here...

    Authors: Shuzhen Chen, Fushi Han, Dongdong Huang, Jinqian Meng, Jiapeng Chu, Meng Wang and Peijun Wang
    Citation: Journal of Translational Medicine 2021 19:337
    Content type: Research Published on:

  11. The glutathione S-transferase P1(GSTP1) is an isoenzyme in the glutathione-S transferases (GSTs) enzyme system, which is the most abundant GSTs expressed in adult lungs. Recent research shows that GSTP1 is clo...

    Authors: Xiao Lei, Lehui Du, Wei Yu, Yao Wang, Na Ma and Baolin Qu
    Citation: Journal of Translational Medicine 2021 19:297
    Content type: Review Published on:

Journal of Translational Medicine

ISSN: 1479-5876

Contact us